Venetoclax shows potential for R/R hairy cell leukemia

Published Date: 13 Mar 2023

Five out of six patients with relapsed or recurrent lymphoma responded to venetoclax alone or in combination with rituximab.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

CDC Alerts on Dramatic Rise in Human Parvovirus B19

2.

What Patients Hear From Us: 'Blah, Blah, Tumor, Blah, Blah, Cancer'

3.

Health of Myeloma Patient's Marriage Tied to Recovery After Transplant

4.

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients

5.

Joe Biden has prostate cancer with bone spread. An oncologist explains what you need to know


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot